Ideas are powerful. They help forge business empires, cure disease, inspire enduring creative work – and much more. Ideas generate IP. And because they’re at the root of innovation and growth, they deserve the very best protection.
Our expertise helps you to protect your IP portfolio and enforce your IP rights worldwide. You’ll put your IP in the safe hands of specialist lawyers who cut their teeth at the forefront of pioneering technology and in well-known, IP-rich companies. So you’ll always have access to a team rich in real world experience – and real industry insight.
Then it’s about going further. Mastering the detail. Simplifying and clarifying. Connecting with you to immerse ourselves in your IP challenges. And generating answers that can give you a competitive edge.
At Bird & Bird we recognise the true value of your IP assets, your ideas and your future. Enabling you to focus on your business, your brand and the difference you make.
Legal 500 UK 2019
The Times Best Law Firms 2019
Chambers Europe-wide 2018
Chambers Global 2018
IAM Patent 1000 2018
Who's Who Legal 2018
Australasian Law Awards 2017
ALB Hong Kong Law Awards 2017
This International Bar Association paper prepared under the leadership of Bird & Bird experts Hein Hobbelen, Francine Cunningham & Baptist Vleeshouwers, takes stock of EU Digital Single Market initiatives and ...
On 3 June 2019, in a recent decision of the Federal Court of Australia in Gram Engineering Pty Ltd v Oxworks Pty Ltd  FCA 689, a rare order was made finding that the patentee is entitled to additional damages for ...
The Singapore Court of Appeal has clarified that liability for trade mark infringement can be established notwithstanding the fact that the infringing goods were merely in transit and never intended for entry into the ...
Bird & Bird has yet again secured a great set of results in the 2019 edition of the IAM Patent 1000 guide to patent practice.
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")
Last night we were awarded 'Global Patent Firm of the Year' at the 5th annual Who's Who Legal Awards in London. This achievement showcases the international strength and quality of our teams and confirms our ...
There are no forthcoming events for this area. Please click on the button below to view past events.
RT @londonipsummit: We are pleased to announce Richard Vary, Partner @twobirdsIP will be discussing #IP landscape 2025 #londonipsummit http…
Deliberate copying: Rare order from Federal Court of Australia finds patentee entitled to additional damages in pat… https://t.co/2PVhjyUZC6